SB2408 would require group health plans and health insurance issuers that cover obstetrical services to also cover fertility treatment, with a broad definition that includes ART, embryo preservation, insemination, genetic testing of embryos, fertility medications, and related services. The bill mirrors these standards across federal programs and the private sector by extending PHSA, ERISA, and the Internal Revenue Code provisions to fertility coverage, and it sets out cost-sharing parity, prohibitions on incentives to deter treatment, and notice requirements.
It also expands coverage to FEHBP, TRICARE,Medicare, and Medicaid where applicable and establishes a rule-making process for interim final regulations. The act is designed to improve access to fertility care while aligning reimbursement and information disclosure across multiple program types.
Key implementation features include definitions that cover the full spectrum of fertility services; a requirement that coverage apply regardless of infertility diagnoses when treatment is prescribed at compliant facilities; a prohibition on discriminatory practices and improper reductions in provider reimbursements; and notice obligations to plan participants. The provisions also introduce coordination across public programs (Medicare, Medicaid, TRICARE) and civilian plans, with phased effective dates and a collective bargaining transition nuance that delays certain requirements for some unionized plans.
At a Glance
What It Does
The bill requires coverage for fertility treatment in applicable plans, defines fertility treatment comprehensively, and sets cost-sharing parity with other medical services. It also prohibits certain incentives and discrimination while mandating notice to participants.
Who It Affects
Affected entities include group health plans, health insurance issuers, FEHB plans, TRICARE, Medicare, and state Medicaid programs, as well as providers and patients seeking fertility care.
Why It Matters
By establishing a nationwide standard for fertility-treatment benefits and aligning cost-sharing, the bill aims to reduce out-of-pocket barriers and ensure access to medically appropriate fertility services across public and private plans.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SB2408 creates a nationwide floor for fertility-treatment coverage within health plans that already cover obstetrical services. It adds a broad, uniform definition of fertility treatment—encompassing preservation of gametes and embryos, artificial insemination, assisted reproductive technologies like IVF, genetic testing of embryos, fertility medications, and gamete donation—and requires plans and issuers to cover these services when they provide obstetrical coverage.
The standard extends beyond private plans to federal programs, including FEHB, TRICARE, Medicare, and Medicaid, through parallel amendments in PHSA, ERISA, and the Internal Revenue Code.
Crucially, the bill ensures cost-sharing parity: out-of-pocket costs for fertility treatments cannot be higher than those for other medical services in the same plan, and interim final regulations will guide implementation. It also prohibits incentives to deter treatment, prevents punitive reimbursements for providers delivering fertility care, and bars discrimination in coverage under listed civil-rights laws.
Plans must notify participants about the coverage in writing, with deadlines tied to regulatory effective dates and annual updates.The act broadens access by creating coverage standards applicable to multiple governance frameworks (federal and state programs, as well as private plans). It contains phased effects—some provisions apply six months after enactment, with a notable collective-bargaining transition that can delay applicability in certain unionized plans—and it extends to veterans' benefits, TRICARE, and state Medicaid plans, creating a unified, though complex, landscape for fertility-care benefits across the health system.
The Five Things You Need to Know
The bill requires group health plans and issuers that cover obstetrical services to also cover fertility treatments.
Fertility treatment is defined broadly to include ART, embryo preservation, insemination, genetic testing, medications, and gamete donation.
Cost-sharing for fertility treatment must be no more burdensome than for other medical services; interim final regulations will govern implementation.
The bill prohibits incentive schemes, provider restrictions, and discriminatory practices related to fertility coverage.
Notice to participants about the fertility-coverage requirement is required, with phased delivery deadlines across plan cycles and regulatory timelines.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Standards Relating to Benefits for Fertility Treatment (PHSA)
The PHSA provision requires a group health plan and a health insurance issuer offering group or individual coverage that includes obstetrical services to provide fertility-treatment coverage. It defines fertility treatment broadly to include preservation of reproductive material, artificial insemination, ART, embryo testing, fertility medications, and related services, as well as other treatments the Secretary determines appropriate. The section also requires coverage when treatment is prescribed at compliant facilities, imposes cost-sharing parity with other medical services, and prohibits discriminatory practices. It also includes a notice requirement and directs the Secretary to issue interim final regulations to implement the cost-sharing standard.
Standards Relating to Benefits for Fertility Treatment (ERISA)
ERISA parallels the PHSA standards for group health plans and health insurance issuers offering group coverage, ensuring that plans governed by ERISA adopt the same fertility-treatment coverage, definitions, and protections. It establishes identical obligations around coverage, patient choice, cost-sharing parity, provider reimbursements, notices, and regulatory guidance, creating cross-cutting consistency for self-insured and fully insured plans under ERISA.
Standards Relating to Benefits for Fertility Treatment (IRS)
The Internal Revenue Code adds a new section creating tax-structure alignment for fertility-treatment coverage. It parallels the PHSA/ERISA requirements and ensures that group health plans must provide fertility treatment coverage in a manner consistent with obstetrical benefits, with the same definition of fertility treatment and notice requirements. This integration helps ensure that tax treatment and employer-sponsored coverage support the intended protections.
Federal Employees Health Benefits Program—Fertility Coverage
Section 8902 of title 5, U.S.C., is amended to require FEHB plans to provide fertility-treatment coverage consistent with 2799A–11. It establishes cost-sharing parity with obstetrical benefits and requires notice to FEHB participants. It also authorizes regulations to implement these requirements within the FEHB framework.
TRICARE Program—Obstetrical and Fertility Benefits
The TRICARE program is amended to require fertility-treatment coverage under plans that include obstetrical benefits. It directs cost-sharing rules to be aligned with 2799A–11, authorizes necessary regulations, and defines fertility treatment for TRICARE beneficiaries.
Fertility Treatment for Veterans and Spouses/Partners
Adds a new section to title 38 requiring the Department of Veterans Affairs to furnish fertility-treatment services to veterans and their spouses or partners upon joint application, with definitions aligned to the 2799A–11 standard. It also requires VA to issue implementing regulations within 18 months.
Medicaid State Plan Requirements for Fertility Treatment
Amends the Social Security Act to require Medicaid to cover fertility treatment in a manner consistent with the Public Health Service Act standards. It provides for the addition to the state plan language and preserves existing family-planning authorities while expanding coverage to fertility services under section KK.
Medicare Coverage for Fertility Treatment
Adds fertility treatment as a covered benefit under Medicare, including payment parity, waivers of certain deductibles, and alignment with the 2799A–11 definitions and treatment scope. It ensures physician-fee-schedule compatibility and payer rules to avoid duplicative or conflicting cost-sharing.
Effective Dates and Collecting Transition
Details the general effective date (plan years starting six months after enactment) and a collective-bargaining transition rule delaying applicability for plans under existing CBAs until later of termination of the current agreements or six months after enactment. It also clarifies how amendments to the plan should conform to new requirements without terminating collective agreements.
Clerical Amendments to Tables and Subparts
Adds required clerical amendments to the table of contents and related cross-references to reflect the new fertility-treatment standards across PHSA, ERISA, and IRC, ensuring statutory consistency and clarity for regulators and plan sponsors.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Individuals and couples seeking fertility treatment who would gain coverage for services including ART, insemination, embryo preservation, genetic testing, and related procedures.
- Fertility clinics and healthcare providers who would be reimbursed under standardized coverage rules, reducing variability in payer decisions.
- Group health plan sponsors and health insurers who would implement a uniform fertility-treatment standard, potentially reducing coverage ambiguity and improving plan design.
- State Medicaid programs and beneficiaries who would see fertility-treatment requirements embedded in state plans, subject to federal standards.
- TRICARE beneficiaries and veterans' families who gain access to fertility services under military health programs and VA implementation.
Who Bears the Cost
- Group health plans and insurers may face higher claims costs and potential premium increases to cover expanded fertility-treatment benefits.
- The federal government (including FEHBP, TRICARE, Medicare) and state governments (Medicaid) could incur higher program expenditures to fund expanded fertility coverage.
- Employers with collective bargaining agreements may experience phased-in implementation, potentially impacting cost-sharing arrangements during transition.
- Fertility treatment providers and clinics may incur administrative costs to comply with new requirements and notice obligations, though they are compensated through standardized reimbursement rules.
Key Issues
The Core Tension
Expanding fertility-treatment coverage swiftly across diverse programs while maintaining budgetary discipline and ensuring regulatory coherence across PHSA, ERISA, IRC, FEHB, TRICARE, Medicare, and Medicaid.
The bill creates comprehensive coverage across multiple federal and state programs, but implementation hinges on a coordinated regulatory approach. Interim final regulations will guide cost-sharing parity and the practical administration of coverage across PHSA, ERISA, and IRC, which can create transitional complexity for plan sponsors that operate under multiple governance regimes.
The cross-cutting nature of the amendments means state-by-state variation in Medicaid expansions and the timing of VA, FEHB, and TRICARE adoption could influence actual access levels in the near term. The collective-bargaining transition provides a practical mechanism to defer certain requirements for plans with active CBAs, but it also introduces a period in which coverage may be inconsistent across employers and issuers depending on bargaining outcomes.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.